Skip to main content

Healthcare Business Intelligence (BI) Market Worth USD 8.9 Billion Reshaping The Healthcare Industry

Healthcare business intelligence is the process by which large scale data from the massive healthcare industry can be collected and refined into actionable insights from key healthcare areas like costs, pharmaceuticals, clinical data, and patient behaviour.

The study involved four major activities to estimate the current size of the market. Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

What the market looks like?

The healthcare business intelligence (BI) market is expected to reach USD 8.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 15.3%.

On the basis of component, the healthcare BI market is segmented into platforms, software, and services. In 2018, the healthcare business intelligence platforms segment are expected to account for the largest share of the market. The large share of this market segment is mainly driven by the increasing requirement for customized BI solutions catering to individual requirements of organizations and allowing them the flexibility to build and integrate BI solutions into existing healthcare business applications for higher efficiency and reduced costs.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252368925

Key Factors Driving Market Growth:

1. Adoption of Data-Driven Decision-Making
2. Implementation of Government Initiatives to Increase EHR Adoption
3. Growing Pressure to Curb Healthcare Spending and Improve Patient Outcomes
4. Big Data in Healthcare
5. Increasing Number of Patient Registries
6. Advanced Analytics Enhancing Traditional Bi
7. Growing Demand for Cloud-Based Healthcare BI Solutions

Key Players in Healthcare Business Intelligence Market:

The market is highly competitive in nature, with several big as well as emerging players. Prominent players in this market include Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US).
Labels:

Comments

Post a Comment

Popular posts from this blog

Best Accounting Software to Kick-start the Business for Smaller Firms – Xero

  Xero Accounting Software is an online software mainly designed for the accounting needs of small business firms. The software can be operated from a PC, phone, tablet, or Mac to view the cash flows of the company in real-time. The software is for small business houses and hence it is simple to use yet smart so that the users can devote most of the time in other important areas of their business. USP of This Software: Xero accounting software offers accounting services to small business firms in a smarter way. Some of the USPs of the software the more than 800apps integrated into the software, secure encryption, support system better performance report generation, and others apart from the basic accounting services offered. Best Accounting Software for Medium-Sized Businesses@ https://blog.360quadrants.com/2020/best-accounting-software-for-medium-sized-businesses/ Xero Pricing Xero accounting software offers 30 days of free trial after which you can choose from any of the pri...
Post a Comment
Read more

Risk-based Monitoring Software Market | Key Factor in Clinical Trial | Market Growth Worth $511 million

  Growth in the risk based monitoring software market can primarily be attributed to factors such as the cost and time efficiency of RBM solutions, rising number of clinical trials, and increasing government funding and grants to support clinical trials. However, the high implementation cost of RBM solutions is expected to restrain the growth of this market during the forecast period. RBM Software Market Dynamics: Impact Analysis 1. Increased outsourcing of clinical trial processes to CROs 2. Cost and time efficiency of RBM solutions 3. Increasing government funding and grants to support clinical trials 4. Increased pharmaceutical R&D spending 5. Initiatives to boost digital health to propel market growth The risk-based monitoring (RBM) software market is expected to reach USD 511 million by 2025 from USD 273 million in 2020, at a CAGR of 13.3% Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102112429 Software Component: The sof...
Post a Comment
Read more

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...
Post a Comment
Read more